Zoriah Aziz

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 20

Top Venues

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Journal of clinical pharmacy and therapeutics

BMC health services research

Therapeutic innovation & regulatory science

University of Malaya

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Malaya

Malaysia

Professor and Head of Department :: Department of Pharmacy, Faculty of Medicine

Publications

Rema Panickar, Zoriah Aziz, Chin Hai Teo, Adeeba Kamarulzaman
Strategies to enhance risk communication about medicines in Malaysia: a Delphi study among multinational experts. BMC health services research 24 (1) (2024)
Noraisyah Mohd Sani, Zoriah Aziz, Adeeba Kamarulzaman
Use of Biosimilars: A Systematic Review of Published Position Statements and Recommendations from Health Organisations and Societies. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2024)
Leong Seng Wang, Zoriah Aziz, Ee Syuen Wang, Zamri Chik
Unused medicine take-back programmes: a systematic review. Journal of pharmaceutical policy and practice 17 (1) (2024)
Rema Panickar, Zoriah Aziz, Chin Hai Teo, Adeeba Kamarulzaman
Strategies to enhance risk communication about medicines in Malaysia: a Delphi study among multinational experts. BMC health services research 24 (1) (2024)
Noraisyah Mohd Sani, Zoriah Aziz, Adeeba Kamarulzaman
Use of Biosimilars: A Systematic Review of Published Position Statements and Recommendations from Health Organisations and Societies. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 38 (3) (2024)
Noraisyah Mohd Sani, Zoriah Aziz, Adeeba Kamarulzaman
Use of Biosimilars: A Systematic Review of Published Position Statements and Recommendations from Health Organisations and Societies. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 38 (3) (2024)
Noraisyah Mohd Sani, Zoriah Aziz, Adeeba Kamarulzaman
Malaysian Hospital Pharmacists' Perspectives and Their Role in Promoting Biosimilar Prescribing: A Nationwide Survey. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 37 (1) (2022)
Noraisyah Mohd Sani, Zoriah Aziz, Adeeba Kamarulzaman
Malaysian Hospital Pharmacists' Perspectives and Their Role in Promoting Biosimilar Prescribing: A Nationwide Survey. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 37 (1) (2022)
Rema Panickar, Zoriah Aziz, Adeeba Kamarulzaman
Enhancing medication risk communication in developing countries: a cross-sectional survey among doctors and pharmacists in Malaysia. BMC public health 22 (1) (2022)
Noraisyah Mohd Sani, Zoriah Aziz, Adeeba Kamarulzaman
Malaysian Hospital Pharmacists' Perspectives and Their Role in Promoting Biosimilar Prescribing: A Nationwide Survey. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 37 (1) (2022)
Noraisyah Mohd Sani, Zoriah Aziz, Adeeba Kamarulzaman
Malaysian Hospital Pharmacists' Perspectives and Their Role in Promoting Biosimilar Prescribing: A Nationwide Survey. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2022)
Noraisyah Mohd Sani, Zoriah Aziz, Adeeba Kamarulzaman
Malaysian Hospital Pharmacists' Perspectives and Their Role in Promoting Biosimilar Prescribing: A Nationwide Survey. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2022)
Noraisyah Mohd Sani, Zoriah Aziz, Rema Panickar, Adeeba Kamarulzaman
Pharmacists' Perspectives of Biosimilars: A Systematic Review. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 36 (4) (2022)
Abuzar Watan Pal, Zoriah Aziz, Adeeba Kamarulzaman
Methodological quality of guidelines for the management of opioid use disorder: A systematic review. Journal of clinical pharmacy and therapeutics 46 (6) (2021)
Rema Panickar, Wee Kee Wo, Norleen M Ali, Min Moon Tang, G R Letchuman Ramanathan, Adeeba Kamarulzaman, Zoriah Aziz
Allopurinol-induced severe cutaneous adverse drug reactions: Risk minimization measures in Malaysia. Pharmacoepidemiology and drug safety 29 (10) (2021)
Noraisyah Mohd Sani, Zoriah Aziz, Adeeba Kamarulzaman
Biosimilars in Malaysia: Regulatory Framework, Approved Products, and Adverse Effects. Therapeutic innovation & regulatory science 55 (3) (2020)
Sameerah Shaikh Abdul Rahman, Zoriah Aziz
Complementary and alternative medicine: Pharmacovigilance in Malaysia and predictors of serious adverse reactions. Journal of clinical pharmacy and therapeutics 45 (5) (2020)
Rahela Ambaras Khan, Zoriah Aziz
Antibiotic de-escalation in patients with pneumonia in the intensive care unit: A systematic review and meta-analysis. International journal of clinical practice 72 (10) (2018)
Vidhya Hariraj, Zoriah Aziz
Patient Reporting of Adverse Drug Reactions (ADRs): Survey of Public Awareness and Predictors of Confidence to Report. Therapeutic innovation & regulatory science 52 (6) (2018)
Rahela Ambaras Khan, Zoriah Aziz
A retrospective study of antibiotic de-escalation in patients with ventilator-associated pneumonia in Malaysia. International journal of clinical pharmacy 39 (4) (2017)

Zoriah Aziz.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Zoriah Aziz